Toxoplasma gondii: DNA vaccination with genes encoding antigens MIC2, M2AP, AMA1 and BAG1 and evaluation of their immunogenic potential

Experimental Parasitology

Volumn 116, Issue 3, 2007, Pages 273-282

  Dautu, George ^a   Munyaka, Biscah ^a,b   Carmen, Gabriella ^a,c   Zhang, Guohong ^a   Omata, Yoshitaka ^a   Xuenan, Xuan ^a   Igarashi, Makoto ^a  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c Servicio Nacional de Salud y Calidad Animal   (Paraguay)

Author keywords

AMA1; apical membrane antigen 1; BAG1; bradyzoite antigen 1; deoxyribonucleic acid; DNA; DNA immunization; IgG; immunoglobulin G; M2AP; MIC2; MIC2 associated protein; microneme protein 2; Toxoplasma gondii

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; BRADYZOITE ANTIGEN 1; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G2C ANTIBODY; MICRONEME PROTEIN 2; PARASITE ANTIGEN; PLASMID DNA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA IMMUNIZATION; EMBRYO; FEMALE; GENE GUN IMMUNIZATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; INFECTION PREVENTION; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BIOLISTICS; CELL LINE; FEMALE; HEAT-SHOCK PROTEINS; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; INTERFERON TYPE II; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; RECOMBINANT PROTEINS; SPLEEN; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; VACCINES, DNA;

MUS; TOXOPLASMA GONDII;

EID: 34248211684     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2007.01.017     Document Type: Article

References (47)

1. Angus C.W., Klivington-Evans D., Dubey J.P., and Kovacs J.A. Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents. The Journal of Infectious Diseases 181 (2000) 317-324
2. Beghetto E., Nielsen H.V., Del Porto P., Buffolano W., Guglietta S., Felici F., Petersen E., and Gargano N. A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts. The Journal of Infectious Diseases 191 (2005) 637-645
3. Bhopale G.M. Development of a vaccine for toxoplasmosis: current status. Microbes and Infection 5 (2003) 457-462
4. Bohne W., Gross U., Ferguson D.J., and Heesemann J. Cloning and characterization of a bradyzoite-specifically expressed gene (hsp30/bag1) of Toxoplasma gondiirelated to genes encoding small heat-shock proteins of plants. Molecular Microbiology 16 (1995) 1221-1230
5. Boyle J.S., Koniaras C., and Lew A.M. Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. International Immunology 9 (1997) 1897-1906
6. + T cells determine cyst number in Toxoplasma gondii infection. Journal of Immunology 145 (1990) 3438-3441
7. Buffolano W., Gilbert R.E., Holland F.J., Fratta D., Palumbo F., and Ades A.E. Risk factors for recent Toxoplasma infection in pregnant women in Naples. Epidemiology and Infection 116 (1996) 347-351
8. Buxton D. Protozoan infections (Toxoplasma gondii, Neospora caninum and Sarcocystis spp.) in sheep and goats: recent advances. Veterinary Research 29 (1998) 289-310
9. Buxton D., and Innes E.A. A commercial vaccine for ovine toxoplasmosis. Parasitology 110 (1995) S11-S16
10. Carruthers V.B., and Sibley L.D. Sequential protein secretion from three distinct organelles of Toxoplasma gondii accompanies invasion of human fibroblasts. European Journal of Cell Biology 73 (1997) 114-123
11. Cesbron-Delauw M.F., and Capron A. Excreted-secreted antigens of Toxoplasma gondii-their origin and role in the host parasite interaction. Research in Immunology 144 (1993) 41-44
12. Denkers E.Y., and Gazzinelli R.T. Regulation and function of T-cell mediated immunity during Toxoplasma gondii infection. Clinical Microbiology Reviews 11 (1998) 569-588
13. Desolme B., Mevelec M.N., Buzoni-Gatel D., and Bout D. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine 18 (2000) 2512-2521
14. Di Cristina M., Del Porto P., Buffolano W., Beghetto E., Spadoni A., Guglietta S., Piccolella E., Felici F., and Gargano N. The Toxoplasma gondii bradyzoite antigens BAG1 and MAG1 induce early humoral and cell-mediated immune responses upon human infection. Microbes and Infection 6 (2004) 164-171
15. Donnelly J.J., Ulmer J.B., and Liu M.A. Immunization with DNA. Journal of Immonological Methods 176 (1994) 145-152
16. Dzierszinski F., Popescu O., Toursel C., Slomianny C., Yahiaoui B., and Tomavo S. The protozoan parasite Toxoplasma gondii expresses two functional plant-like glycolytic enzymes. Implications for evolutionary origin of apicomplexans. The Journal of Biological Chemistry 274 (1999) 24888-24895
17. Fatoohi A.F., Cozon G.J., Greenland T., Ferrandiz J., Bienvenu J., Picot S., and Peyron F. Cellular immune responses to recombinant antigens in pregnant women chronically infected with Toxoplasma gondii. Clinical and Diagnostic Laboratory Immunology 9 (2002) 704-707
18. Gazzinelli R.T., Hieny S., Wynn T.A., Wolf S., and Sher A. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proceedings of the National Academy of Sciences of the United States of America 90 (1993) 6115-6119
19. Haddad D., Liljeqvist S., Stahl S., Perlmann P., Berzins K., and Ahlborg N. Differential induction of immunoglobulin G subclasses by immunization with DNA vectors containing or lacking a signal sequence. Immunology Letters 61 (1998) 201-204
20. Hughes H.P. Toxoplasmosis: the need for improved diagnostic techniques and accurate risk assessment. Current Topics in Microbiology and Immunology 120 (1985) 105-139
21. Huygen K., Content J., Denis O., Montgomery D.L., Yawman A.M., Deck R.R., De Witt C.M., Orme I.M., Baldwin S., D'Souza C., Drowart A., Lozes E., Vandenbussche P., Van Vooren J.P., Liu M.A., and Ulmer J.B. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nature Medicine 2 (1996) 893-898
22. Ismael A.B., Sekkai D., Collin C., Bout D., and Mevelec M.N. The MIC3 gene of Toxoplasma gondiiis a novel potent vaccine candidate against toxoplasmosis. Infection and Immunity 71 (2003) 6222-6228
23. Jouvin-Marche E., Morgado M.G., Leguern C., Voegtle D., Bonhomme F., and Cazenave P.A. The mouse Igh-1a and Igh-1b H chain constant regions are derived from two distinct isotypic genes. Immunogenetics 29 (1989) 92-97
24. Klinman D.M., Yi A.K., Beaucage S.L., Conover J., and Krieg A.M. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proceedings of the National Academy of Sciences of the United States of America 93 (1996) 2879-2883
25. Le Gros G., Ben-Sasson S.Z., Seder R., Finkelman F.D., and Paul W.E. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4 producing cells. The Journal of Experimental Medicine 172 (1990) 921-929
26. Leyva R., Herion P., and Saavedra R. Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii. Parasitology Research 87 (2001) 70-79
27. + T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. The Journal of Experimental Medicine 184 (1996) 597-607
28. Lourenço E.V., Bernardes E.S., Silva N.M., Mineo J.R., Panunto-Castelo A., and Roque-Barreira M.C. Immunization with MIC1 and MIC4 induces protective immunity against Toxoplasma gondii. Microbes and Infection 8 (2006) 1244-1251
29. Luft B.J., and Remington J.S. Toxoplasmic encephalitis in AIDS. Clinical Infectious Diseases 15 (1992) 211-222
30. Martin R.M., and Lew A.M. Is IgG2a a good Th1 marker in mice?. Immunology Today 19 (1998) 49
31. Mohamed R.M., Aosai F., Chen M., Mun H.S., Norose K., Belal U.S., Piao L.X., and Yano A. Induction of protective immunity by DNA vaccination with Toxoplasma gondii HSP70, HSP30 and SAG1 genes. Vaccine 21 (2003) 2852-2861
32. Mun H.S., Aosai F., and Yano A. Role of Toxoplasma gondii HSP70 andToxoplasma gondii HSP30/bag1 in antibody formation and prophylactic immunity in mice experimentally infected with Toxoplasma gondii. Microbiology and Immunology 43 (1999) 471-479
33. Nass P.H., Elkins K.L., and Weir J.P. Antibody response and protective capacity of plasmid vaccines expressing three different herpes simplex virus glycoproteins. The Journal of Infectious Diseases 178 (1998) 611-617
34. Ogra P.L., Faden H.S., Abraham R., Duffy L.C., Sun M., and Minor P.D. Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines. The Journal of Infectious Diseases 164 (1991) 191-194
35. Quelle F.W., Shimoda K., Thierfelder W., Fischer C., Kim A., Ruben S.M., Cleveland J.L., Pierce J.H., Keegan A.D., Nelms K., Paul W.E., and Ihle J.N. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in response to IL-4 and IL-3 but are not required for mitogenesis. Molecular and Cellular Biology 15 (1995) 3336-3343
36. Saito S., Aosai F., Rikihisa N., Mun H.S., Norose K., Chen M., Kuroki T., Asano T., Ochiai T., Hata H., Ichinose M., and Yano A. Establishment of gene-vaccinated skin grafting against Toxoplasma gondii infection in mice. Vaccine 19 (2001) 2172-2180
37. Sambrook J., and Russell D.W. Preparation and transformation of competentE. coli. Molecular Cloning 3 (2001) 16.30-16.32
38. Sato Y., Roman M., Tighe H., Lee D., Corr M., Nguyen M.D., Silverman G.J., Lotz M., Carson D.A., and Raz E. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273 (1996) 352-354
39. Soldati D., Dubremetz J.F., and Lebrun M. Microneme proteins: structural and functional requirements to promote adhesion and invasion by the apicomplexan parasite Toxoplasma gondii. International Journal for Parasitology 31 (2001) 1293-1302
40. Stevenson F.K., and Rosenberg W. DNA vaccination: a potential weapon against infection and cancer. Vox Sanguinis 80 (2001) 12-18
41. Striepen B., Soldati D., Garcia-Reguet N., Dubremetz J.F., and Roos D.S. Targeting of soluble proteins to the rhoptries and micronemes in Toxoplasma gondii. Molecular and Biochemical Parasitology 113 (2001) 45-53
42. Suzuki Y., Orellana M.A., Schreiber R.D., and Remington J.S. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 240 (1988) 516-518
43. Svanholm C., Bandholtz L., Lobell A., and Wigzell H. Enhancement of antibody responses by DNA immunization using expression vectors mediating efficient antigen secretion. Journal of Immunological Methods 228 (1999) 121-130
44. Swain S.L., Weinberg A.D., English M., and Huston G. IL-4 directs the development of Th2-like helper effectors. Journal of Immunology 145 (1990) 3796-3806
45. Tomley F.M., and Soldati D.S. Mix and match modules: structure and function of microneme proteins in apicomplexan parasites. Trends in Parasitology 17 (2001) 81-88
46. Torres C.A., Yang K., Mustafa F., and Robinson H.L. DNA immunization: effect of secretion of DNA-expressed hemagglutinins on antibody responses. Vaccine 18 (1999) 805-814
47. Vercammen M., Scorza T., Huygen K., De Braekeleer J., Diet R., Jacobs D., Saman E., and Verschueren H. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infection and Immunity 68 (2000) 38-45